Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute pyelonephritis or other complicated urinary tract infection due to gram negative pathogens~Exclusion Criteria:~* ileal loops or vesicoureteral reflux~* complete obstruction of any portion of urinary tract, perinephric or intrarenal abscess.~* fungal urinary tract infection~* permanent indirect catheter or nephrostomy unless removed within 48 hours of study entry~* history hypersensitivity to study medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): NXL/104 ceftazidime
- 2 (Type: ACTIVE_COMPARATOR): comparator 4 x daily

Based on this trial design, predict the completion outcome and termination type (if applicable).